MSD to acquire EyeBio

Start-up developing new treatment options for patients with retinal diseases

03-Jun-2024 - Merck & Co., known as MSD outside of the United States and Canada, and EyeBiotech Limited (EyeBio), a privately held ophthalmology-focused biotechnology company, announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire ...

SeaBeLife awarded over €1.5 million in i-Nov innovation competition

Funding for company’s SeaBeEYE project will be used to develop new therapeutic approach for geographic atrophy – advanced form of dry AMD

29-Apr-2024 - SeaBeLife, a biotechnology company developing drug candidates intended to block cellular necrosis, announces the award of more than €1.5M ($1.6M) in financing for its SeaBeEYE project at the i-Nov 2024 innovation competition. Funded by the French government’s France 2030 investment plan and ...

How your eye color affects your health

Iris color - a little noticed risk factor

15-Jun-2023 - From light blue or gray to greenish and deep brown tones: the iris or iris of the eye can take on a whole range of color shades. But the color of the eye not only determines a significant part of the external appearance. As is known today, the color of the iris is also related to the tendency to ...

Rentschler Biopharma joins forces with Ikarovec to accelerate novel gene therapies

Ikarovec is developing novel gene therapies to treat serious, but common eye diseases

06-Jun-2023 - Rentschler Biopharma SE and Ikarovec, which is developing novel multicistronic gene therapies to treat major ophthalmic indications, announced that the two companies have entered into a collaboration. Under the agreement, Rentschler Biopharma’s ATMP site in Stevenage, UK, will support the ...

New Potential Mechanism for Vision Loss Discovered

Visual cells may not simply die in some diseases, but are mechanically transported out of the retina beforehand

05-Dec-2022 - Thanks to laboratory produced human mini-retinas, researchers were able to observe complex changes in the retina as they occur in macular degeneration. This enabled them to discover the so-called cell extrusion as a potential mechanism for neurodegenerative diseases. Visual cells in the human ...

Restoring vision by gene therapy

Latest scientific findings give hope for people with incurable retinal degeneration

09-Jun-2020 - Humans rely dominantly on their eyesight. Losing vision means not being able to read, recognize faces or find objects. Macular degeneration is one of the major reasons for visual impairment, round the globe, close to 200 million people are affected. Photoreceptors in the retina are responsible to ...

Protein closely linked to commonest cause of blindness

10-Feb-2020 - An international team of scientists has identified a protein which is strongly linked to the commonest cause of blindness in developed countries when its levels are raised in the blood. The discovery is a major step forward in the understanding of age-related macular degeneration, which affects ...

Eye scan makes diseases visible at an early stage

10-Sep-2019 - More and more people over 50 are suffering from age-related vision disorders. According to the World Health Organization, in four out of five cases they could be avoided if they were diagnosed at an early stage. A European team of scientists, including the Leibniz Institute of Photonic Technology ...

OMEICOS Therapeutics Closes €17m Series C Financing

Advancing lead candidate towards pivotal trials

05-Nov-2018 - OMEICOS Therapeutics, a Berlin-based biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases, announced the closing of a EUR 17 million (approx. USD 19.5 million) Series C financing led by new ...

Genetic mutations that lead to macular degeneration blindness mapped by new research

08-Nov-2016 - Two gene mutations that trigger a retinal disease that causes blindness in one in 5,000 males have been mapped, leading to the potential for new therapeutic treatments. Researchers from The University of Manchester undertook a structural analysis of X-linked Retinoschisis (XLRS), a genetic ...